← Back to Ipca Laboratories Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

IPCALABPharmaceuticals

Ipca Laboratories Ltd — Financial Ratios & Key Metrics

₹1601.20

+1.02%

P/E Ratio36.41xIndustry: 31.77x

ROE12.75%Return on equity

ROCE14.72%Return on capital

Debt/Equity0.17Low debt

💎

Valuation & Profitability

P/E Ratio

36.41x

Industry Average P/E

31.77x

Dividend Yield

0.28%

Market Cap

₹36.04K (Cr)

Sales Growth 5Y

14.01%

Profit Growth 5Y

7.24%

EPS Growth 5Y

7.16%

OPM 5Y Avg

20.22%

📉

Price Returns

1 Month

+11.75%

3 Months

+3.88%

6 Months

+1.77%

1 Year

-7.91%

52W Low

₹1168

Current

₹1601

52W High

₹1624

95% of 52-week range — Near highs

🔬

Technical Indicators

Overbought

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50

₹1495

▲ Price above SMA 50 — Bullish

SMA 200

₹1417

▲ Long-term uptrend

Volume Signal

141% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Ipca Laboratories Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.